Ikonisys
Biotechnology, 5 Science Park Ste 2, Parigi, Connecticut, 06511, United States, 11-50 Employees
Phone Number: +12*********
Who is IKONISYS
Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated ...
Read More
-
Headquarters: 5 Science Park Ste 2, Parigi, Connecticut, 06511, United States
-
Date Founded: 1999
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7371
|
NAICS Code: 621511 |
Show More
Ikonisys Org Chart and Mapping
Email
Phone
Similar Companies to Ikonisys
QCDx
-
1-10
-
$ 1 Million to 5 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Ikonisys
Answer: Ikonisys's headquarters are located at 5 Science Park Ste 2, Parigi, Connecticut, 06511, United States
Answer: Ikonisys's phone number is +12*********
Answer: Ikonisys's official website is https://ikonisys.com
Answer: Ikonisys's revenue is $10 Million to $25 Million
Answer: Ikonisys's SIC: 7371
Answer: Ikonisys's NAICS: 621511
Answer: Ikonisys has 11-50 employees
Answer: Ikonisys is in Biotechnology
Answer: Ikonisys top competitors include: QCDx
Answer: Ikonisys contact info: Phone number: +12********* Website: https://ikonisys.com
Answer: Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease. Through its breakthrough fluorescence microscopy platform, Ikonisys continues to develop a stream of oncology tests for a variety of cancers. At the center of the platform is the Ikoniscope20, a robotic, high-throughput, microscopy system that provides a true walk away automated solution. In addition to providing high quality cell images, the platform analyzes the cells of interest, offering an interpretation of the analysis, to facilitate the quick, accurate reporting of the test result. In addition to automating traditional FISH-based tests, the rare cell detection and analysis capabilities of the platform, that facilitates the examination of large complex samples for the clinically relevant cells, make it particularly suitable for circulating tumor cell-based testing.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month